144 related articles for article (PubMed ID: 37207703)
1. Iris melanoma: Prognostication for metastasis.
Melendez-Moreno A; Yeşiltaş YS; Wrenn J; Singh AD
Surv Ophthalmol; 2023; 68(5):957-963. PubMed ID: 37207703
[TBL] [Abstract][Full Text] [Related]
2. Personalized Prognosis of Uveal Melanoma Based on Cytogenetic Profile in 1059 Patients over an 8-Year Period: The 2017 Harry S. Gradle Lecture.
Shields CL; Say EAT; Hasanreisoglu M; Saktanasate J; Lawson BM; Landy JE; Badami AU; Sivalingam MD; Hauschild AJ; House RJ; Daitch ZE; Mashayekhi A; Shields JA; Ganguly A
Ophthalmology; 2017 Oct; 124(10):1523-1531. PubMed ID: 28495150
[TBL] [Abstract][Full Text] [Related]
3. Variation of monosomy 3 status within uveal melanoma.
Schoenfield L; Pettay J; Tubbs RR; Singh AD
Arch Pathol Lab Med; 2009 Aug; 133(8):1219-22. PubMed ID: 19653713
[TBL] [Abstract][Full Text] [Related]
4. Variability of Bad Prognosis in Uveal Melanoma.
Shao YF; Echegaray JJ; Singh N; Singh AD
Ophthalmol Retina; 2019 Feb; 3(2):186-193. PubMed ID: 31014770
[TBL] [Abstract][Full Text] [Related]
5. Genetic findings in treatment-naïve and proton-beam-radiated iris melanomas.
Krishna Y; Kalirai H; Thornton S; Damato BE; Heimann H; Coupland SE
Br J Ophthalmol; 2016 Jul; 100(7):1012-1016. PubMed ID: 27098748
[TBL] [Abstract][Full Text] [Related]
6. Chromosomal aberrations in iris melanomas.
Mensink HW; Vaarwater J; de Keizer RJ; de Wolff-Rouendaal D; Mooy CM; de Klein A; Paridaens D
Br J Ophthalmol; 2011 Mar; 95(3):424-8. PubMed ID: 20881029
[TBL] [Abstract][Full Text] [Related]
7. Gene Expression Profiling Prognostication of Posterior Uveal Melanoma: Does Size Matter?
Binkley EM; Bena JF; Davanzo JM; Hinz C; Boldt HC; Singh AD
Ophthalmol Retina; 2020 Jun; 4(6):620-629. PubMed ID: 32081600
[TBL] [Abstract][Full Text] [Related]
8. In vivo monosomy 3 detection of posterior uveal melanoma: 3-year follow-up.
Midena E; Bonaldi L; Parrozzani R; Radin PP; Boccassini B; Vujosevic S
Graefes Arch Clin Exp Ophthalmol; 2008 Apr; 246(4):609-14. PubMed ID: 17934749
[TBL] [Abstract][Full Text] [Related]
9. Prognostic parameters in uveal melanoma and their association with BAP1 expression.
van Essen TH; van Pelt SI; Versluis M; Bronkhorst IH; van Duinen SG; Marinkovic M; Kroes WG; Ruivenkamp CA; Shukla S; de Klein A; Kiliç E; Harbour JW; Luyten GP; van der Velden PA; Verdijk RM; Jager MJ
Br J Ophthalmol; 2014 Dec; 98(12):1738-43. PubMed ID: 25147369
[TBL] [Abstract][Full Text] [Related]
10. The in vivo modulatory effects of an anterior-chamber microenvironment on uveal melanoma.
Mudhar HS; Saunders E; Rundle P; Rennie IG; Sisley K
Br J Ophthalmol; 2009 Apr; 93(4):535-40. PubMed ID: 19019926
[TBL] [Abstract][Full Text] [Related]
11. Genetic Background of Iris Melanomas and Iris Melanocytic Tumors of Uncertain Malignant Potential.
van Poppelen NM; Vaarwater J; Mudhar HS; Sisley K; Rennie IG; Rundle P; Brands T; van den Bosch QCC; Mensink HW; de Klein A; Kiliç E; Verdijk RM
Ophthalmology; 2018 Jun; 125(6):904-912. PubMed ID: 29371009
[TBL] [Abstract][Full Text] [Related]
12. Genome-wide profiling is a clinically relevant and affordable prognostic test in posterior uveal melanoma.
Cassoux N; Rodrigues MJ; Plancher C; Asselain B; Levy-Gabriel C; Lumbroso-Le Rouic L; Piperno-Neumann S; Dendale R; Sastre X; Desjardins L; Couturier J
Br J Ophthalmol; 2014 Jun; 98(6):769-74. PubMed ID: 24169649
[TBL] [Abstract][Full Text] [Related]
13. Analysis of chromosomal aberration (1, 3, and 8) and association of microRNAs in uveal melanoma.
Radhakrishnan A; Badhrinarayanan N; Biswas J; Krishnakumar S
Mol Vis; 2009 Oct; 15():2146-54. PubMed ID: 19898689
[TBL] [Abstract][Full Text] [Related]
14. RELATIONSHIP OF CLINICAL FEATURES AND BASELINE TUMOR SIZE WITH GENE EXPRESSION PROFILE STATUS IN UVEAL MELANOMA: A Multi-institutional Study.
Berry D; Seider M; Stinnett S; Mruthyunjaya P; Schefler AC;
Retina; 2019 Jun; 39(6):1154-1164. PubMed ID: 29578940
[TBL] [Abstract][Full Text] [Related]
15. Metabolic activity of primary uveal melanoma on PET/CT scan and its relationship with monosomy 3 and other prognostic factors.
Papastefanou VP; Islam S; Szyszko T; Grantham M; Sagoo MS; Cohen VM
Br J Ophthalmol; 2014 Dec; 98(12):1659-65. PubMed ID: 25084771
[TBL] [Abstract][Full Text] [Related]
16. Validation of the Prognostic Usefulness of the Gene Expression Profiling Test in Patients with Uveal Melanoma.
Miguez S; Lee RY; Chan AX; Demkowicz PC; Jones BSCL; Long CP; Abramson DH; Bosenberg M; Sznol M; Kluger H; Goldbaum MH; Francis JH; Pointdujour-Lim R; Bakhoum MF
Ophthalmology; 2023 Jun; 130(6):598-607. PubMed ID: 36739981
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors in uveal melanoma.
Singh AD; Shields CL; Shields JA
Melanoma Res; 2001 Jun; 11(3):255-63. PubMed ID: 11468514
[TBL] [Abstract][Full Text] [Related]
18. Ciliary body melanoma with partial deletion of chromosome 3 detected with multiplex ligation-dependent probe amplification.
Damato EM; Damato B; Sibbring JS; Coupland SE
Graefes Arch Clin Exp Ophthalmol; 2008 Nov; 246(11):1637-40. PubMed ID: 18563430
[TBL] [Abstract][Full Text] [Related]
19. Iris and Ciliary Body Melanocytomas Are Defined by Solitary GNAQ Mutation Without Additional Oncogenic Alterations.
Solomon DA; Ramani B; Eiger-Moscovich M; Milman T; Uludag G; Crawford JB; Phan I; Char DH; Shields CL; Eagle RC; Bastian BC; Bloomer MM; Pekmezci M
Ophthalmology; 2022 Dec; 129(12):1429-1439. PubMed ID: 35835335
[TBL] [Abstract][Full Text] [Related]
20. Transcriptomic versus chromosomal prognostic markers and clinical outcome in uveal melanoma.
Worley LA; Onken MD; Person E; Robirds D; Branson J; Char DH; Perry A; Harbour JW
Clin Cancer Res; 2007 Mar; 13(5):1466-71. PubMed ID: 17332290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
